Bee Granted is committed to building an ecosystem that covers the entire technology transfer value chain, from ideation to market introduction and scale-up.
To this end, we are happy to announce a new collaboration with Heyen Consult, a Berlin-based consultancy company that offers expertise at the intersection of drug development, regulatory affairs, patient safety and quality. Heyen Consult has a global reach, with previous clients from Europe (including Switzerland), India, USA. In addition to regulatory expertise, quality management and pharmacovigilance, Heyen Consult can assist our clients in the product development plan area, including TPP, CDP preparation and early HTA considerations from a scientific perspective, representing an extended area of collaboration. In turn, Bee Granted can offer project financing advice (non-dilutive and dilutive) and can support the development of business strategies for the implementation of innovative healthcare technologies.
Alex Neagu, PhD, Director of Strategy and Innovation Management at Bee Granted: “We are confident that this collaboration will bring significant benefits to our clients active in healthcare, who will now have streamlined access to key expertise that will assist them in improving the world tomorrow by employing a 360 degrees view on product strategy today.”
Petra Heyen, PhD, founder and owner of Heyen Consult: “Our collaboration will allow our mutual customers to concentrate on their core business - the innovation. We will help them to bring more projects more quickly in front of regulatory agencies. This will give patients earlier access to the most innovative health care products and procedures”.
Get in touch with us to discuss how this collaboration can benefit you!